Ghizzi A, de Caro L, Bensi L, Berti P
Laboratorio di Colture Cellulari, Università degli Studi di Pavia.
Boll Soc Ital Biol Sper. 1991 Jun;67(6):553-60.
The in vitro action of folic acid was tested on the proliferation of bone marrow granulocyte-macrophage progenitor cells from a patient with drug-induced (propyphenazone) neutropenia in remission 20 days after the drug had been suspended. Various bone marrow cultures were prepared with standard stimulant, adding, respectively: folic acid, propyphenazone and both folic acid and propyphenazone together. Growth was tested on day 7, 12 and 19 of incubation. Under baseline culture with standard stimulant, CFU-GM growth was characterized by successive proliferation waves of various entity: the first on day 7 was very high, the second, on day 12 was rather low, and the third, on day 19 was intermediate. This behaviour is different from what is usually observed in normal subjects in steady-state, whose first (AC-A+AC-B) and second (AC-C) proliferation period are of similar entity. The prevalence of the first proliferation period in our case is interpreted as the result of a renewed granulocytopoietic activity after drug-induced bone marrow suppression. This indicates a maintained integrity of the negative-feedback mechanism of homeostatic regulation on granulocytopoietic activity. The sole addition of propyphenazone on the in vitro bone marrow cell cultures of our patient produced a reduction of those CFU-GM that had grown during the first period whereas the growth during the second and third period remained unvaried. Thus the growth peak in cultures treated with propyphenazone occurred on day 19, which seems to correspond with the necessary time for a spontaneous remission from neutropenia, clinically observed to be 20 days after suspension of the propyphenazone-containing drug.(ABSTRACT TRUNCATED AT 250 WORDS)
对一名药物性(异丙安替比林)中性粒细胞减少症患者在停用药物20天后处于缓解期的骨髓粒细胞-巨噬细胞祖细胞增殖情况进行了叶酸的体外作用测试。制备了各种含标准刺激物的骨髓培养物,分别添加:叶酸、异丙安替比林以及叶酸和异丙安替比林两者。在培养的第7天、12天和19天测试生长情况。在含标准刺激物的基础培养条件下,CFU-GM生长的特征是不同实体的连续增殖波:第7天的第一个波峰非常高,第12天的第二个波峰相当低,第19天的第三个波峰处于中间水平。这种行为与稳态下正常受试者通常观察到的情况不同,正常受试者的第一个(AC-A + AC-B)和第二个(AC-C)增殖期实体相似。我们病例中第一个增殖期的优势被解释为药物性骨髓抑制后粒细胞生成活性重新激活的结果。这表明粒细胞生成活性稳态调节的负反馈机制保持完整。在我们患者的体外骨髓细胞培养物中单独添加异丙安替比林,使在第一个时期生长的CFU-GM数量减少,而第二个和第三个时期的生长保持不变。因此,用异丙安替比林处理的培养物中的生长峰值出现在第19天,这似乎与中性粒细胞减少症自发缓解所需的时间相对应,临床观察到在停用含异丙安替比林的药物后20天缓解。(摘要截短至250字)